Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
cefTRIAXone
cefTRIAXone
Formulary Duration Restrictions
Limited to 6 weeks without TLC approval.
Cell Status
NFISA
Brand names:
CefTRIAXone Sodium, Rocephin
Form
Strength
POWDER FOR INJECTION, INJECTABLE
1 g; 250 mg
Additional Information:
MARCH 2019 P&T MINUTES
Last updated:
Aug. 23, 2021
FDA Drug Safety:
Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Ceftriaxone for Injection and Dextrose Injection in the Duplex Container
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
MARCH 2019 P&T MINUTES